ReviewCancers2025

Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review.

Benjamin Derman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.